Merkel cell carcinoma and melanoma: Etiological similarities and differences

Cancer Epidemiology Biomarkers and Prevention

Volumn 8, Issue 2, 1999, Pages 153-158

  Miller, Robert W ^a   Rabkin, Charles S ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; EPIDEMIOLOGICAL DATA; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; MELANOMA; MERKEL CELL TUMOR; ONSET AGE; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; RACE; SUN EXPOSURE; ULTRAVIOLET B RADIATION;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGE FACTORS; AGED; AGED, 80 AND OVER; CARCINOMA, MERKEL CELL; ENVIRONMENTAL EXPOSURE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FACIAL NEOPLASMS; FEMALE; HUMANS; IMMUNOSUPPRESSION; INCIDENCE; LYMPHOMA, B-CELL; MALE; MELANOMA; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; NEOPLASMS, SECOND PRIMARY; ORGAN TRANSPLANTATION; POPULATION SURVEILLANCE; REGISTRIES; SEER PROGRAM; SKIN NEOPLASMS; SUNLIGHT; ULTRAVIOLET RAYS; UNITED STATES;

EID: 0033011983     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Tang, C., and Toker, C. Trabecular carcinoma of the skin: an ultrastructural study. Cancer (Phila.), 42: 2311-2321, 1978.
2. Vortmeyer, A. O., Merino, M. J., Boni, R., Liotta, L. A., Cavazzana, A., and Zhuang, Z. Genetic changes associated with primary Merkel cell carcinoma. Am. J. Clin. Pathol., 109: 565-570, 1998.
3. Young, J. L. Jr, Percy, C. L., and Asire, A. J. Surveillance, Epidemiology, and End Results: incidence and mortality data, 1973-77. NCI Monogr., 57: 1-9, 1981.
4. Scotto, J., Fears, T. R., and Fraumeni, J. F., Jr. Solar radiation. In: D. Schottenfeld and J. F. Fraumeni, Jr. (eds.). Cancer Epidemiology and Prevention, pp. 359-362. New York: Oxford University Press, 1996.
5. Ries, L. G., Pollack, E. S., and Young, J. L. Cancer patient survival: Surveillance, Epidemiology and End-Results Program 1973-79. J. Natl. Cancer Inst., 70: 693-707, 1983.
6. Rabkin, C. S., Biggar, R. J., Melbye, M., and Curtis, R. E. Second primary cancers following anal and cervical carcinoma: evidence of shared etiologic factors. Am. J. Epidemiol., 136: 54-58, 1992.
7. Magrath, I. T. Introduction: concepts and controversies in lymphoid neoplasia. In: I. T. Magrath (ed.), The Non-Hodgkin's Lymphomas, p. 21. New York: Oxford University Press, 1997.
8. Silva, E. G., Mackay, B., Goedert, H., Burgess, M. S., and Fields, R. A. Endocrine carcinoma of the skin (Merkel cell carcinoma). Pathol. Annu., 19: Part 2:1-30, 1984.
9. Eftekhari, F., Wallace, S., Silva, E. G., and Lenzi, R. Merkel cell carcinoma of skin: imaging and clinical features in 93 cases. Br. J. Radiol., 69: 226-233, 1996.
10. Kuhajda, F. P., Olson, J. L., and Mann, R. B. Merkel cell (small cell) carcinoma of the skin: immunohistochemical and ultrastructural demonstration of distinctive perinuclear cytokeratin aggregates and a possible association with B cell neoplams. Histochem. J., 18: 239-244, 1986.
11. Safidi, R., Pappo, O., Sviri, S., and Eldor, A. Merkel cell carcinoma in a woman with chronic lymphocytic leukemia. Leuk. Lymphoma, 20: 509-511, 1996.
12. Quaglino, D., Di Leonardo, G., Lalli, G., Pasqauloni, E., Simone, S., Vecchio, L., and Ventura, T. Association between chronic lymphocytic leukaemia and secondary tumours: unusual occurrence of a neuroendocrine (Merkel cell) carcinoma. Eur. Rev. Med. Pharmacol. Sci., 1: 11-16, 1997.
13. Brenner, B., Katz, A., Rakowski, E., Feinmesser, M., Hanna, M. B., Sulkes, A., and Fenig, E. Merkel cell carcinoma in Israel. Isr. J. Med. Sci., 32: 1235-1238, 1996.
14. Pilotti, S., Rilke, F., Baroli, C., and Grisotti, A. Clinicopathologic correlations of cutaneous neuroendocrine Merkel cell carcinoma. J. Clin. Oncol., 6: 1863-1873, 1988.
15. Boyle, F., Pendlebury, S., and Bell, D. Further insights into the natural history and management of primary cutaneous neuroendocrine (Merkel cell) carcinoma. Int. J. Radiat. Oncol. Biol. Phys., 31: 315-323, 1995.
16. Dantal, J., Hourmant, M., Cantarovitch, D., Giral, M., Blanche, G., Dreno, B., and Soulillou, J-P. Effect of long-term immunosuppression in kidney-graft recipients in cancer incidence: randomised comparison of two cyclosporin regimens. Lancet, 351: 623-628, 1998.
17. Formica, M., Basolo, B., Funaro, L., Mazzucco, G., Segoloni, G. P., and Piccoli, G. Merkel cell carcinoma in renal transplant recipient. Nephron, 68: 399, 1994.
18. Douds, A. C., Mellotte, G. J., and Morgan, S. H. Fatal Merkel-cell tumour (cutaneous neuroendocrine carcinoma) complicating renal transplantation. Nephrol. Dial. Transplant., 10: 2346-2348, 1995.
19. Gooptu, C., Woollons, A., Ross, J., Price, M., Wojnarowska, F., Morris, P. J., Wall, S., and Bunker, C. B. Merkel cell carcinoma after therapeutic immunosuppression. Br. J. Dermatol., 137: 637-641, 1997.
20. Williams, R. H., Morgan, M. B., Mathieson, I. M., and Rabb, H. Merkel cell carcinoma in a renal transplant patient: increased incidence? Transplantation, 65: 1196-1197, 1998.
21. Stempfle, H. U., Mudra, H., Angermann, C. E., Weiss, M., Reichart, B., and Theisen, K. Rapid growth of cutaneous neuroendocrine (Merkel cell) carcinoma during treatment of refractory cardiac allograft rejection with OKT3 monoclonal antibody. J. Heart Lung Transplant., 12: 501-503, 1993.
22. Pham, S. M., Kormos, R. L., Landreneau, R. J., Kawai, A., Gonzalez-Cancel, I., Hardesty, R. L., Hattler, B. G., and Griffith, B. P. Solid tumors after heart transplantation: lethality of lung cancer. Ann. Thorax Surg., 60: 1623-626, 1995.
23. Veness, M. J. Aggressive skin cancers in a cardiac transplant recipient. Australas. Radiol., 41: 363-366, 1997.
24. Takahashi, Y., Miyakawa, K., Nagatani, T., Ishiyama, S., Baba, N., Nakajima, H., Kitamura, H., Anze, M., Hirai, I., and Shimoda, N. A case of Merkel cell carcinoma of the pinna. Clin. Dermatol. (Jpn), 44: 419-424, 1990.
25. Kayashima, K. Symposium. Merkel cell carcinoma in Japan. J. Dermatol. (Jpn). 23: 436, 1996.
26. Fitzpatrick, T. B. Enigma of the pathogenesis of primary melanoma: changing incidence and mortality in Japan and the United States. J. Invest. Dermatol., 92: 234S-236S, 1989.
27. Luande, J., Henschke, C. I., and Mohammed, N. The Tanzanian human albino skin. Natural history. Cancer (Phila.), 15: 1823-1828, 1985.
28. Lookingbill, D. P., Lookingbill, G. L., and Leppard, B. Actinic damage and skin cancer in albinos in northern Tanzania: findings in 164 patients in an outreach skin care program. J. Am. Acad. Dermatol., 32: 653-658, 1995.
29. Kromberg, J. G., Castle, D., Zwane, E. M., and Jenkins, T. Albinism and skin cancer in Southern Africa. Clin. Genet., 36: 43-52, 1989.
30. Aquaron, R. Oculocutaneous albinism in Cameroon. A 15-year follow-up study. Ophthalmic Paediatr. Genet., 11: 255-1263, 1990.
31. Weinstock, M. A. Human models of melanoma. Clinics Dermatol., 10: 83-89, 1992.
32. Ihn, H., Nakamura, K., Abe, M., Furue, M., Takehara, K., Nakagawa, H., and Ishibashi, Y. Amelanotic metastatic melanoma in a patient with oculocutaneous albinism. J. Am. Acad. Dermatol., 28: 895-900, 1993.
33. Levine, E. A., Ronan, S. G., Shirali, S. S., and Das Gupta, T. K. Malignant melanoma in a child with oculocutaneous albinism. J. Surg. Oncol., 51: 138-142, 1992.
34. Kheterpal, S., Shields, J. A., Shields, C. L., De Potter, P., Ehya, H., and Eng, K. Y. Choroidal melanoma in an African-American albino. Am. J. Ophthalmol., 122: 901-902, 1989.
35. Goldstein, A. M., Falk, R. T., Fraser, M. C., Dracopoli, N. C., Sikurski, R. S., Clark, W. H., Jr, and Tucker, M. A. Sun-related risk factors in melanoma-prone families with CDKN2A mutations. J. Natl. Cancer Inst., 90: 709-710, 1998.
36. Elwood, J. M. Epidemiology and control of melanoma in white populations and in Japan. J. Invest. Dermatol., 92: 214S-221S, 1989.
37. Stevens, N. G., Liff, J. M., and Weiss, N. S. Plantar melanoma: is the incidence of melanoma of the sole of the foot really higher in blacks than whites? Intl. J. Cancer, 45: 691-693, 1990.
38. Jimbow, K., Horikoshi, T., Takahashi, H., Akutsu, Y., and Maeda, K. Fine structural and immunohistochemical properties of dysplastic melanocytic nevi: comparison with malignant melanoma. J. Invest. Dermatol., 92: 304S-309S, 1989.
39. Hara, K., Nitta, Y., and Ikeya, T. Dysplastic nevus syndrome among Japanese. A case study and review of the Japanese literature. Am. J. Dermatopathol., 14: 24-31, 1992.
40. Greene, M. H. Genetics of cutaneous melanoma and nevi. Mayo Clin. Proc., 72: 467-474, 1997.
41. Tucker, M. A., Halpern, A., Holly, E. A., Hartge, P., Elder, D. E., Sagebiel, R. W. Guery, D., and Clark, W. H., Jr. Clinically recognizable dysplastic nevi. A central risk factor for cutaneous melanoma. J. Am. Med. Assn., 277: 1439-1444, 1997.
42. Bataille, Y., Bishop, N., Sasieni, P., Swerdlow, A. J., Pinney, E., Griffiths, K., and Cuzick, J. Risk of cutaneous melanoma in relation to the numbers, types and sites of naevi: a case-control study. Br. J. Cancer, 73: 1605-1611, 1996.
43. Penn, I. Malignant melanoma in organ allograft recipients. Transplantation, 61: 274-278, 1996.
44. House, N. S., Fedok, F., Maloney, M. E., and Helm, K. F. Malignant melanoma with clinical and histologic features of Merkel cell carcinoma. J. Am. Acad. Dermatol., 31: 839-842, 1994.
45. Kraemer, K. H., Lee, M-M., Andrews, A. D., and Lambert, W. C. The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer. Arch. Dermatol., 130: 1018-1021, 1994.
46. Kraemer, K. H., Lee, M. M., and Scotto, J. Xeroderma pigmentosum. Cutaneous, ocular, and neurologic abnormalities in 830 published cases. Arch. Dermatol., 123: 241-250, 1987.
47. Lunder, E., and Stern, R. S. Merkel cell carcinoma in patients treated with methoxsalen and ultraviolet A radiation. New Engl. J. Med., 339: 1247-1248, 1998.
48. Kukita, A., and Ishihara, K. Clinical features and distribution of malignant melanoma and pigmented nevi on the soles of the feet in Japan. J. Invest. Dermatol., 92: 210S-213S, 1989.
49. Travis, L., Curtis, R. E., Glimelius, B., Hollaway, E., Van Leeuwen, F. E., Lynch, C. F. Adami, J., Gaspodarowicz, M., Wacholder, S., Inskip, P., Tucker, M. A., Fraumeni, J. F., Jr., and Boice, J. D., Jr. Second cancers among long-term survivors of non-Hodgkin's lymphoma. J. Natl. Cancer Inst., 85: 1932-1937, 1993.
50. Travis, L. B., Curtis, R. E., Boice, J. D., Jr., Hankey, B. F., and Fraumeni, J. F., Jr. Second cancers following non-Hodgkin's lymphoma. Cancer (Phila.), 67: 2002-2009, 1991.
51. Travis, L. B., Curtis, R. E., Hankey, B. F., and Fraumeni, J. F. Jr. Second cancers in patients with chronic lymphocytic leukemia. J. Natl. Cancer Inst., 84: 1422-1427, 1992.
52. Gridley, G., Klippel, J. H., Hoover, R. N., and Fraumeni, J. F., Jr. Incidence of cancer among men with the Felty syndrome. Ann. Intern. Med., 120: 35-39, 1994.
53. Catlett, J. P., Todd, W. M., and Carr, M. E., Jr. Merkel cell tumor in an HIV-positive patient. VA Med. Q., 119: 256-258, 1992.
54. Selik, R. M., and Rahkin, C. S. Cancer death rates associated with human immunodeficiency virus infection in the United States. J. Natl. Cancer Inst., 90: 1300-1302, 1998.
55. Cerroni, L., and Kerl, H. Primary cutaneous neuroendocrine (Merkel cell) carcinoma in association with squamous-and basal-cell carcinoma. Am. J. Dermatopathol., 19: 610-613, 1997.